A new report published by Transparency Market Research (TMR) presents a comprehensive study about the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market at level. The report explores several possibilities for the key market players by identifying the primary growth drivers and inhibitors of the market, and prevalent market trends and consequent opportunities.According to the market research report, titled “Human Papillomavirus and Cytomegalovirus Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014- 2020”, the global human papillomavirus (HPV) market was valued at US$1,402.3 million in 2012 and is expected to reach a value of US$2,346.5 million by 2020, growing at a CAGR of 7.7% from 2014 to 2020, while the cytomegalovirus (CMV) therapeutics market was valued at US$870.1 million in 2012 and is expected to reach US$922.8 million by 2020, growing at a CAGR of 1.49 % from 2014 to 2020.
Browse the full Human Papillomavirus (By Drug Class and Applications) and Cytomegalovirus (By Drug Type and Applications) Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at https://www.transparencymarketresearch.com/hpv-cmv-therapeutics-market.html
Cytomegalovirus (CMV) and human papillomavirus (HPV) are viral pathogens that can adversely harm individuals at any age. CMV is a virus that often affects immunocompromised individuals such as those suffering from HIV, while HPV leads to dangerous sexually transmitted diseases (STDs). The group of human papillomaviruses includes over 100 viral strains. Only a few out of this group eventually cause warts or papillomas, which can progress to benign or malignant tumors. Cytomegalovirus infections are caused by a virus that remains dormant in the body for a long time. Some of the sources of this virus are body fluids such as semen, saliva, blood, urine, and breast milk.The global HPV therapeutics market is segmented on the basis of drug class and applications. Various drug classes used for fighting HPV infections are keratolytic agents, immunomodulators, sinecatechins, and anti-neoplastic agents. On the basis of applications, the HPV therapeutics market is divided into genital cancers, genital warts, oral papillomas, epidermodysplasia verriformis, and others such as oropharyngeal cancer and laryngeal papillomatosis.
The global CMV therapeutics market is similarly segmented on the basis of drugs and applications. The drugs segment of CMV therapeutics market includes valganciclovir, foscarnet, ganciclovir, and cidofovir. The CMV therapeutics treatment is used against infections such as gastrointestinal ulcers, retinitis, encephalitis, pneumonia, and others such as mouth ulcers and pharyngitis.The HPV therapeutics market is led by immunomodulators, which hold the biggest market share, while analysts suggest that the sinecatechins segment is likely to grow at an accelerated pace. The CMV therapeutics market is dominated by ganciclovir and valganciclovir, which hold more than 85% of the market share.
Geographically, South America and Asia Pacific are the promising markets for the CMV and HPV therapeutics markets due to growing investment in healthcare infrastructure, tourism, large prevalence of STDs, and rising disposable incomes.
The key player in the HPV market is Valeant Pharmaceuticals with a share of more than 70% in the global market, while the CMV therapeutics market is dominated by Roche AG with a market share of over 85%. Some of the other important players in the market are Fougera Pharmaceuticals, Clinigen Group plc, Perrigo Company plc, and Fresenius Kabi USA.
Browse : Our new press releases https://www.transparencymarketresearch.com/pressrelease/global-hpv-cmv-therapeutics-industry.htm
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453